

Why We Recommend a Hybrid Approach to Clinical Trials, An Interview with VirTrial VP of Operations, Kim Kundert
There is a lot of discussion surrounding the introduction of virtual platforms into the clinical trial space and pharmaceutical sponsors are taking various approaches. As a result, these varying solutions provide different experiences for everyone involved. The...
How Virtual Visits Support a Patient-Centric Approach to Clinical Trials
Rapid advancements in technology are spurring disruption in nearly every industry, and the biotech and pharmaceutical markets are no exception. From biosensors and 3D bioprinting to gene editing and tissue engineering, there is no doubt that significant evolution is...